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Abstract
Liver cancer or hepatocellular carcinoma is one of the leading causes of cancer-related deaths. Conventional
chemotherapies are limited by the development of drug resistance and various side effects. Because of its non-toxicity
and potent biopharmacological activity, metabolites derived from mushrooms have received more attention in cancer
therapy. Our previous studies have demonstrated the anticancer effects of polysaccharide-protein complexes derived from
the Pleurotus mushrooms. The aim of this study was to investigate the underlying molecular mechanism of the anticancer
activity of a hot water extract containing a polysaccharide-protein complex isolated from Pleurotus pulmonarius (PP) in liver
cancer cells. Our results indicated that exposure of liver cancer cells to PP not only significantly reduced the in vitro cancer
cell proliferation and invasion but also enhanced the drug-sensitivity to the chemotherapeutic drug Cisplatin. Both oral
administration and intraperitoneal injection of PP significantly inhibited the tumor growth in xenograft BALB/c nude mice.
PP triggered a marked suppression of the PI3K/AKT signaling pathway in liver cancer cells in vitro and in vivo, and
overexpression of the constitutively active form of AKT, Myr-AKT, abrogated this effect and the inhibited proliferation and
invasion by PP. Both western blot and ELISA results showed that PP-treated liver cancer cells had reduced expression and
secretion of vascular endothelial growth factor (VEGF). Addition of recombinant human VEGF attenuated the inhibitory
effects of PP on PI3K/AKT pathway and the cancer phenotypes. Our results demonstrated that PP suppressed the
proliferation, invasion, and drug-resistance of liver cancer cells in vitro and in vivo, mediated by the inhibition of autocrine
VEGF-induced PI3K/AKT signaling pathway. This study suggests the potential therapeutic implication of PP in the treatment
of human liver cancer.
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Introduction
Liver cancer is the fifth most prevalent cancer and the third
leading cause of all cancer-related deaths in the world [1–3].
Unfortunately, the overall response rate of liver cancer to
treatment is unsatisfactory mainly due to the late diagnosis and
poor efficacy of therapies, especially the resistance to chemother-
apeutic drugs and metastasis to other organs [4]. The alternations
of multiple cell signaling pathways were frequently observed in a
broad variety of human cancers, including liver cancer, in which
the PTEN/PI3K/AKT signaling cascade has been reported to
play a crucial role in the regulation of the malignant behaviors
including proliferation, survival and invasion [5,6]. Emerging
evidences demonstrated that PI3K/AKT pathway can be
regulated in an autocrine manner by various growth factors, such
as insulin-like growth factor (IGF) and vascular endothelial growth
factor (VEGF) [7,8].
Natural phytochemicals and metabolites from plants are
receiving increasing attention for their pharmacological effects in
treatment and prevention of cancer because of their low toxicity
and potential biological activity [9]. Both in vitro and in vivo studies
have shown that these bioactive natural products can inhibit the
initiation, promotion, and progression of carcinogenesis by
interfering the signaling pathways in human cancer cells and their
consumption has become a promising chemopreventive and
chemotherapeutic strategy against cancers [10,11]. Among them,
edible mushrooms are known to be a rich source of anticancer
agents, with their polysaccharides and polysaccharide-protein
complexes being the most efficacious ones [12,13]. Numerous
reports have demonstrated the in vitro and in vivo anticancer
activities of polysaccharides isolated from edible mushrooms such
as Lentinula edodes, Agaricus blazei and Phellinus linteus against different
human cancer cells [14–18]. A recent study demonstrated that
crude extract of polysaccharide from Phellinus linteus inhibited the
phosphorylation of AKT in breast cancer cells [19]. Crude extract
of the polysaccharides present in Ganoderma lucidum was found to
have anti-metastatic effects through the modulation of the PI3K/
AKT pathway [20].
Recently, there are many in vitro studies demonstrating the
antioxidant and anti-proliferative effect of crude extracts of
polysaccharides and polysaccharide-protein complexes from the
Pleurotus mushroom genus in different human cancer cells [2–25].
The antioxidant activity of many natural products has also been
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e34406suggested to contribute to their anticancer effect [26–28]. Based
on the antioxidant study of the mushroom species collection in our
laboratory, an active polysaccharide and protein complex isolated
from mushroom Pleurotus pulmonarius, coded as PP, was screened
out for potential anticancer agent due to its significant antioxidant
effect (Unpublished data) in this study. These intriguing prelim-
inary findings have led us to investigate the underlying molecular
mechanisms of the anti-carcinogenic effect by which PP exerted on
two human liver cancer cells, Huh7 and Hep3B. These results
demonstrated for the first time that inhibition of VEGF/PI3K/
AKT cascade mediated the in vitro and in vivo suppressive effects of
PP on the development and progression of human liver cancer
cells. The chemosensitization of the liver cancer cells towards
therapeutic drug cisplatin was also enhanced by PP treatment. In
the present study, the therapeutic potential of PP in the treatment
of human hepatocellular carcinoma was implicated.
Results
In vitro anti-proliferative effect of PP on liver cancer cells
To determine the inhibitory effect of PP on liver cancer cells, we
first evaluated the growth and viability of four liver cancer cell
lines (Huh7, Hep3B, HepG2 and SMMC-7721) with treatment of
PP by using MTT assay. The results showed that PP exerted a
significant inhibitory effect on Huh7, Hep3B, HepG2 and
SMMC-7721 cells in dose- and time-dependent manner
(Fig. 1A). This finding was further confirmed by colony-formation
assay (Fig. 1B). Flow cytometry analysis showed that the treatment
of liver cancer cells PP caused an accumulation of cells in the G2
phases (an increase from 12.4260.25 to 19.6661.12 in Huh7 and
from 13.3061.04 to 20.3861.11 in Hep3B) (Table 1). In addition,
consistent with the slightly increased sub-G1 population in PP-
treated cells (Table 1), the important apoptosis markers, cleaved
caspase3 and cleaved Poly (ADP-ribose) polymerase (PARP) were
up-regulated in PP-treated cells, suggesting the proapoptotic effect
of PP on liver cancer cells may be caspase-mediated. Western blot
indicated a dose-dependent reduction in the expression of cyclin
B1, an important G2 checkpoint protein, in the two liver cancer
cells, suggesting that PP-induced G2 phase cell cycle arrest might
be mediated by the down-regulated expression of cyclin B1
(Fig. 1C). Meanwhile, to exclude the possibility that the anti-
cancer effect of polysaccharide-protein complex isolated from
Pleurotus pulmonarius are non-specific, polysaccharide-protein com-
plex isolated from another Pleurotus mushroom, Pleurotus tuber-regium
(PTR) was applied as control, thus suggesting the specific effect of
PP (Fig. S1).
On the other hand, PP was examined for cytotoxic effects
against normal liver cell WRL-68 by using MTT assay and colony
formation assay. The results demonstrated that normal liver cell
WRL-68 are more resistant to PP than liver cancer cells,
suggesting the selective cytotoxicity of PP to cancer cells and its
potential to be developed as anticancer agents (Fig. S2). To further
investigate the potential implication of PP in the treatment of
human cancers, we extended our studies in other cancer types.
The results indicated a significant reduced proliferation rate in a
dose-dependent manner upon PP treatment in human cancer cell
lines from breast (T47D), lung (A549), stomach (AGS), and
prostate (DU145) (Fig. S3).
Effect of PP on the inhibition of VEGF expression and
inactivation of PI3K/AKT pathway
Western blot showed that treatment of PP notably reduced
protein expressions of phospho-AKT (p-AKT), the activated form
of AKT, and its downstream targets including phospho-GSK3b
(p-GSK3b), Survivin, Bcl-xL in a dose-dependent manner, but not
that of Bax and total level of AKT and GSK3b in both liver
cancer cells (Fig. 2A). In addition, consistent with the slightly
increased sub-G1 population in PP-treated cells (Table 1), the
important apoptosis markers, cleaved caspase3 and cleaved Poly
(ADP-ribose) polymerase (PARP) were up-regulated in PP-treated
cells, suggesting the proapoptotic effect of PP on liver cancer cells
may be caspase mediated. Meanwhile, N-cadherin and Vimentin,
which may account for reversal of epithelial-mesenchymal
transition (EMT), were down-regulated in PP-treated cells
(Fig. 2A). In contrast, expression level of phospho-ERK (p-
ERK), another important signaling pathway involved in cancer
cell regulation, was not substantially altered upon PP treatment,
suggesting the specificity in the regulation of PI3K/AKT pathway
by PP (Fig. 2A). Huh7 cells transiently transfected with AKT-
plasmid consistently revealed an abrogated inhibitory effect when
exposure to PP as indicated by MTT assay (Fig. 2B) and western
blot analysis (Fig. 2C). These findings further confirmed that
PI3K/AKT signaling pathway might contribute to the anticancer
effects of PP in liver cancer cells.
Effect of PP on the inhibition of VEGF secretion and
inactivation of PI3K/AKT pathway
It is interesting to find that PP reduced the expression of
VEGF which is an important growth factor involved in
proliferation and invasion of human cancer [29]. It has been
well documented that PI3K/AKT pathway is activated in
response to various growth factors [30]. Given that our western
blot results showed reduced protein expressions of p-AKT and
VEGF but not Phosphatase and tensin homolog (PTEN), an
upstream protein of AKT (Fig. 2A), it is very likely that PP
regulates PI3K/AKT pathway through a VEGF-mediated
autocrine manner. Interestingly, ELISA data demonstrated a
suppression of VEGF secretion in a dose-dependent manner
upon PP treatment in Huh7 and Hep3B cells (Fig. 3A). Most
importantly, addition of recombinant human VEGF (rhVEGF)
at 0.6 ng/ml, the concentration reduced by PP compared to
untreated group at 72 hr time point, attenuated the inhibitory
effect of PP on cell proliferation (Fig. 3B) and PI3K/AKT signal
pathway (Fig. 3C). These data suggest that the inactivation of
PI3K/AKT pathway by PP may be mediated by the inhibition
of VEGF in an autocrine manner.
Effect of PP on enhancing the chemosensitivity of liver
cancer cells to cisplatin
A large body of evidence has indicated that PI3K/AKT
pathway critically contributes to drug resistance in human cancer
[31] and inactivation of PI3K/AKT by PP might lead to
alternation of drug sensitivity in liver cancer cells. From the
colony formation assay, cisplatin (DDP) at 5 mMo r1 0mM only
slightly decreased the cell viability, whereas a significant synergistic
effect on colony formation in Huh7 and Hep3B cells was observed
when DDP was combined with a low concentration of PP (25 mg/
ml) (Fig. 4A), suggesting that PP might be a sensitizer for the
chemotherapeutic drug. Transfection of AKT plasmid (Fig. 4B)
and addition of rhVEGF (0.6 ng/ml) (Fig. 4C) resulted in an
abrogated sensitization, further supporting the vital role of AKT
pathway and VEGF played in the regulation of liver cancer cells
by PP.
PP decreases the invasive potential of liver cancer cells
Using chamber invasion assay, it was found that PP at a low
dosage (50 mg/ml) which had no significant effects on cell
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invasiveness of Huh7 and Hep3B cells (Fig. 5A). Interestingly,
the inhibitory effect of PP on the invasion of Huh7 was attenuated
by overexpression of constitutively activated AKT (Fig. 5B) and
addition of rhVEGF (Fig. 5C), further demonstrating the
involvement of VEGF/PI3K/AKT cascade in the regulation of
liver cancer cells by PP. In addition, a dose-dependent reduced
expression levels of N-cadherin and Vimentin, the important
makers for cell migration and invasion, was noted in western blot
analysis shown in Fig. 2A, supporting the observed inhibitory
effect of PP on the invasiveness of liver cancer cells.
PP significantly suppresses human liver cancer xenograft
growth in nude mice
Considering the above in vitro results showing that PP reduced
the proliferation of liver cancer cells, it will be crucial to evaluate
whether PP could inhibit tumorigenicity of liver cancer cells in vivo.
Firstly, nude mice with established s.c tumor xenograft from Huh7
cells was employed and treated with either oral administration or
intraperitoneal (i.p.) injection of PP. Both the oral feeding and i.p
injection of PP significantly (p,0.001) impaired the tumor growth
(Fig. 6A) although the effect by oral administration (inhibition ratio
,82%) was less pronounced comparing with i.p injection
(inhibition ratio ,99%).
Tumor xenograftes harvested from the four groups of mice
were subjected to immunohistochemistry and western blot
analysis. A significantly lower percentage of Ki-67-positive cells
found in PP-treated group compared with control group (Fig. 6B)
suggested that the inhibitory effect of PP might be due to
decreased cell proliferation. The alternation of protein expres-
sion in the PP-treated xenograft animals, including a down-
regulated expression of p-AKT, P-GSK3b,B c l - x L ,a n da nu p -
regulated expression of cleaved caspase-3 in these in vivo
experiments (Fig. 6C) were consistent with those in vitro studies
(Fig. 2A).
Furthermore, no obvious side effects or changes were
observed by comparing the histological features of internal
organs including the liver, lung and kidney (Fig. 7A) and body
weight of the animals (Fig. 7B) in the treatment and control
groups, suggesting the safety and clinical implication of PP as an
anticancer agent.
Discussion
In this study we demonstrated that PP, a hot water extract
containing a polysaccharide-protein complex isolated from
Pleurotus pulmonarius inhibited the development and progression of
liver cancer cells in vitro and in vivo. Such anticancer effects are
through the inhibition of VEGF-mediated autocrine regulation of
PI3K/AKT pathway. The significance of these findings is
discussed below.
Firstly, we demonstrated that treatment of PP reduced
tumorigenicity of liver cancer cells in the xenograft nude mouse
model without any obvious side effect. Despite the advancement in
chemotherapeutics in recent years, chemotherapy is still associated
with serious side effects, such as nephrotoxicity, nausea, hair loss,
skin irritation, anemia, infertility [32,33]. Therefore, naturally
occurring anticancer compounds present in human diets have
important implication of chemotherapy and chemoprevention,
especially for those with low toxicity and high potency such as
resveratrol [34] and tea polyphenols [35]. More interestingly, the
Pleurotus pulmonarius fruit body extracts have been reported to delay
the progression of chemically induced hepatocellular carcinoma in
CBA mice [36]. In this study, we found that both i.p injection and
oral administration of PP remarkably inhibited the tumor growth.
The comparatively less pronounced tumor inhibition observed in
oral administration of PP might be due to the pharmacokinetic
limitations and intestinal degradation of the compounds [37]. No
significant differences were found by comparing the histology of
lung, liver, kidney and body weight in the PP-treated and control
mice, suggesting that there was no observable adverse health effect
on mice treated with PP. The remarkable anticancer effects and
low toxicity to animals lend support to the feasibility of PP for
human liver cancer treatment.
Secondly, the present results indicated that PP inhibited the
proliferation rate of liver cancer cells, and this effect may be
through G2 cell cycle arrest. Interestingly, besides the G2 phase,
the simultaneous accumulations in S phase were observed, the
possible molecular mechanisms warrant further investigation. In
addition, our data showed that PP significantly increased the drug
sensitivity of liver cancer cells to cisplatin (Fig. 4). Despite the
recent advancement in the development of chemotherapies in the
past decades, most patients eventually relapsed after treatment,
implying that tumors acquired mechanisms of drug resistance,
Figure 1. Effects of PP on the proliferation of liver cancer cell lines. A. MTT assay was taken to evaluate the liver cancer cell (Huh7, Hep3B,
HepG2 and SMMC-7721) viability after the treatment with different concentrations of PP (0, 25, 50, 100, 200 or 400 mg/ml respectively) for up to 96 hr.
Data are means (bars, SD) of three independent experiments. B. The colony-formation assay demonstrated a dose-dependent decrease in liver cancer
cell proliferation (Huh7, Hep3B, HepG2 and SMMC-7721) when exposure to PP. C. Western blot was conducted and a dose-dependent reduction of
cyclin B1 expression was observed. Actin was involved as a loading control.
doi:10.1371/journal.pone.0034406.g001
Table 1. Representative cell cycle distribution by flow cytometry.
Huh7 Hep3B
PP (mg/ml) 0 50 200 0 50 200
SubG1 (%) 1.4660.32 1.5160.17 4.2361.04* 1.0860.34 1.7660.55 3.3660.60*
G0/G1 (%) 55.9462.25 52.1361.79 36.3462.30** 62.6461.95 56.1661.11 36.2361.25**
S (%) 30.1662.01 30.8762.09 39.7562.24* 22.9660.65 26.8061.76 40.0262.34**
G2 (%) 12.4260.25 15.4860.96 19.6661.12** 13.3061.04 15.2761.98 20.3861.11**
Huh7 and Hep3B cells were treated with PP (0, 50 or 100 mg/ml) for 48 hr, harvested and subjected to flow cytometry analysis of their DNA content. Data are means6SD
of three independent experiments. Significant differences between the PP-treated and untreated cells were statistically analyzed by ANOVA (Tukey’s multiple
comparison test; *, P,0.05; **, P,0.005).
doi:10.1371/journal.pone.0034406.t001
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[38]. In order to overcome chemoresistance, chemosensitization
which is based on the combination of another drug by regulating
one or more mechanisms of resistance has been taken as one
attractive strategy, especially the involvement of natural existing
compounds [39]. Interestingly, a large body of evidence is
emerging to indicate that several signaling pathways are critically
involved in mediating acquired resistance to chemotherapeutic
drugs in human cancer, including PI3K/AKT, MEK/ERK, JNK
and AMPK pathways [40,41]. The inhibition of PI3K/AKT
pathway by pharmacologic approach could lead to restoration of
drug sensitivity [42,43]. In this regard, inactivation of PI3K/AKT
by PP (Fig. 2 and 3) suggested that exposure to PP might enhance
the drug susceptibility of liver cancer cells. Furthermore, the fact
that PP-induced down-regulation of Bcl-xL and Surviven (Fig. 2A),
both of which are important makers of multi-drug resistance,
further showed the promising role of PP as chemosensitizer.
Another highlight should be addressed is that the PP treatment
resulted in a reduced invasiveness of liver cancer cells (Fig. 5A),
which was further supported by the decreased protein expressions
of N-cadherin and vimentin in PP-treated cells (Fig. 2A). It had
been reported that N-cadherin is crucial for tumor-vessels
interactions, extravasation and metastatic dissemination [44,45]
and vimentin is widely used as a marker accounting for the
epithelial to mesenchymal transition (EMT) [46,47]. EMT is a
trans-differentiation program required for tissue morphogenesis
during embryonic development. However, it can adversely cause
organ fibrosis and promote carcinoma progression through a
variety of mechanisms, acquiring invasive and metastatic proper-
ties [48–50]. The investigation of EMT inhibitor has opened new
door for controlling metastasis which crucially contributes to the
high mortality rate of liver cancer [51]. Therefore, the present
findings in the inhibitory effects of PP on the invasive potential of
liver cancer cells have clinical implication in the treatment of liver
cancer.
Besides the functional study, elucidation of the mechanisms is
crucial for understanding the PP as potential anticancer agent.
Since the constitutive activation of PI3K/AKT signaling cascade
is frequently observed in human cancer phenotypes and crucially
related with cancer cell proliferation, survival, invasion and
angiogenesis, the inhibition of PI3K/AKT pathway has become
an attractive approach for liver cancer treatment [52,53]. AKT
inhibitors have been reported to suppress the tumor growth in
liver, suggesting the rational for targeting the PI3K/AKT pathway
in this disease. However, the employment of AKT inhibitor is
associated with unexpected side effects [54]. Cordyceps militaris,a
medicinal mushroom, was reported to induce cell cycle arrest and
apoptosis through inactivation of PI3K/AKT pathway in breast
cancer [55]. Also, oral administration of a polyphenolic fraction
isolated from green tea significantly inhibits prostate cancer
development and metastasis through PI3K/AKT pathway in
transgenic adenocarcinoma of mouse model [56]. Interestingly,
Figure 2. PP exerts its anticancer effect through inactivation of PI3K/AKT signaling pathway. A. Huh7 and Hep3B cells were treated with
different concentrations of PP (0, 50 or 100 mg/ml) and cell lysis harvested at 48 hr for western blot analysis. PP treatment exerted a significant
reduction in expression levels of p-AKT and its downstream targets including p-GSK-3b, Bcl-xL, and survivin. However, PP did not affect expressions of
p-ERK and PTEN but VEGF expression was decreased in PP-treated cells. The experiments were repeated 3 times. B. Huh7 cells were transfected with
AKT-overexpressing vector or the vector control, then treated with PP (50 mg/ml) and the cell viability measured by MTT at 72 hr. The results revealed
an abrogated inhibitory effect in AKT-transfected cells when compared with the control. Data are given as percentage of untreated cells as control
which was set at 100%. Data are means 6 SD of three independent experiments. C. Huh7 cells were transfected with AKT-overexpressing vector or
the vector control and then treated with PP. Cell lysate was harvested and applied to western blot. Significant differences between the PP-treated
and untreated cells were statistically analyzed by ANOVA (Tukey’s multiple comparison test; *, P,0.01; **, P,0.001).
doi:10.1371/journal.pone.0034406.g002
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AKT, the active form of PI3K/AKT, in a dose dependent
manner, in line with the result of functional study. In addition, the
results of parallel experiments by transfection of AKT plasmid
consistently illustrated an abrogated inhibitory effect of PP, further
confirming the involvement of PI3K/Akt signaling cascade (Fig. 2B
and 2C).The deregulation of PI3K/AKT pathway significantly
contributed to the development of hepatocellular carcinoma [57].
Personalized approaches based on a refinement of the molecular
classification of HCC, have been taken as potential strategies in
the clinical treatment of HCC [58]. Meanwhile, the identification
of reagents that interfere with signaling pathways which contribute
to HCC might lead to the development of personalized therapies
for the patients, and thereby maximize the efficacy and cost benefit
[59]. This study provides a novel potential therapeutic option for
the patients presented with constitutive PI3K/AKT activation. On
the other hand, although no obvious alternations were observed in
ERK pathway when exposure to PP, the effect of PP on other
signaling pathways warrants further investigation.
Interestingly, it was found that VEGF was down-regulated at
both protein expression and secretion levels upon PP treatment. In
addition, stimulation of the cells with rhVEGF in the culture
medium attenuated the inhibitory effect of PP on AKT pathway
and cancer phenotypes (Fig. 3). Carcinogenesis is a multi-step
process mediated by many growth factors including placental
growth factor (PIGF), platelet-derived growth factor (PDGF), and
Vascular Endothelial Growth Factor (VEGF) [60]. In the tumor
microenvironment, the various growth factors control not only the
cancer cells but also the stromal in autocrine and paracrine
manner [61,62]. VEGF is one of the key factors responsible for
angiogenesis which controls the formation of new blood vessels
from existing vasculature, and plays an essential role in tumor
growth, invasion and metastasis [63,64]. There are studies
demonstrated that the extract of Phellinus linteus could significantly
suppress the angiogenesis through the downregulation of VEGF
secretion by targeting AKT in breast cancer or through Wnt/b-
catenin signaling pathway in colon cancer [65,66]. Anti-angio-
genic therapy based on inhibition of VEGF/VEGF receptor is
believed to be powerful clinical strategy in the treatment of cancer,
especially for liver cancer which is a highly vascular tumor
[67,68].The inhibitory effect of PP on VEGF suggests the anti-
angiogenic activities of PP and its potential implication in anti-
angiogenic therapy. In this study, the new findings related to the
inhibition of VEGF/PI3K/AKT cascade in liver cancer cells by
PP treatment provide insights into the molecular mechanisms to
support its potential clinical application.
In conclusion, PP, a Pleurotus mushroom polysaccharide-protein
complex, has both in vitro and in vivo anticancer activities against
liver cancer cells through the inhibition of secretory VEGF-
mediated autocrine regulation of PI3K/AKT signaling. Further
studies on the anticancer effect of the Pleurotus mushroom
polysaccharide-protein complex on liver cancer stem cancers will
be carried out to evaluate its potential application in cancer
treatment and prevention.
Materials and Methods
Preparation and characterization of mushroom hot water
extract
Edible mushroom (Pleurotus pulmonarius) was purchased from the
local supermarket and the species was positively identified based
on its morphology. Dried powder was prepared from grinding the
freeze-dried mushroom fruiting bodies into particle size less than
0.5 mm and then subjected to a hot water extraction at 95–100uC
for 3 hr with a sample-to-solvent ratio of 1:25 (w/v). The mixture
was centrifuged 10000 g at 4uC for 30 min and the supernatant
was dialyzed with dialysis membrane tubing (molecular weight cut-
off of 6000 to 8000, Spectrum Laboratories, CA) and freeze-dried
to give the hot water extract designated as PP For cell culture
study, a solution of PP was sterilized with 0.22 mm pore size filter
prior to use. Limulus Amebocyte Lysate test kit (Sigma, MI) was
used to show that endotoxin contamination was below 0.05 EU/
Figure 3. Inhibition of VEGF expression and secretion by PP
mediates its effects on PI3K/AKT pathway. A. Effects of PP on
secretion of VEGF in Huh7 and Hep3B cells. After the cells were treated
by PP with various concentrations of (0, 50 or 100 mg/ml) for 48 hr, the
conditioned medium were collected and VEGF level in the conditioned
medium was determined by a human VEGF ELISA Kit. The result
demonstrated a suppression of VEGF secretion in a dose-dependent
manner upon PP treatment. B. MTT assay was performed to evaluate
the proliferation when exposure to PP (50 mg/ml) in presence or
absence of rhVEGF (0.6 ng/ml) for 72 hr in Huh7 cells. C. Huh7 cells
were treated with PP (50 mg/ml) alone or the combination with rhVEGF
(0.6 ng/ml), and cell lysate was harvested and applied to western blot.
Data are expressed as mean 6 SD. Significant differences between the
PP-treated and untreated cells were statistically analyzed by ANOVA
(Tukey’s multiple comparison test; *, P,0.01; **, P,0.001).
doi:10.1371/journal.pone.0034406.g003
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e34406Figure 4. Synergistic effect of PP with cisplatin (DDP) in liver cancer cells. A. Huh7 and Hep3B cell were treated with DDP (up to 10 mM), PP
(25 mg/ml), or the combination and then colony formation assay performed. B. Huh7 cells were transfected with AKT-overexpressing vector or the
vector control, then treated with low dosage of PP (25 mg/ml), DPP (5 mM), or the combination for 72 hr and the cell viability measured by MTT assay.
C. MTT assay was performed to evaluate the proliferation when exposure to low dosage of PP (25 mg/ml), DDP (5 mM) alone or the combination, in
the absence or presence of rhVEGF for 72 hr in Huh7 cells. Addition of rhVEGF (0.6 ng/ml) led to an abrogated sensitization. Data are given as
percentage of untreated controls which were set at 100%, with mean 6 SD of at least three independent experiments. Significant differences
between the PP-treated and untreated cells were statistically analyzed by ANOVA (Tukey’s multiple comparison test; *, P,0.01; **, P,0.001).
doi:10.1371/journal.pone.0034406.g004
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e34406Figure 5. Effect of PP on invasive potential of liver cancer cells. A. Boyden chamber assay was used to determine the invasiveness of Huh7
and Hep3B cells upon treatment with control or PP (50 mg/ml) PP for 24 hr. PP significantly suppressed liver cancer cell invasion. Right panel showed
the quantification by submerging the chambers in 1% SDS and measuring the absorbance of the solution at 570 nm. The mean of triplicate assays for
each experiment condition was calculated and values normalized to the untreated cells. B. The Huh7 cells transfected with AKT-overexpressing
vector, or the vector control were treated with PP, and the cell invasiveness was tested. Right panel shows the quantification. C. Huh7 cells were
treated with PP in the absence or presence of 0.6 ng/ml rhVEGF, and the invasive potential determined. Right panel shows the quantification. Data
are expressed as mean 6 SD. Significant differences between the PP-treated and untreated cells were statistically analyzed by ANOVA (Tukey’s
multiple comparison test; *, P,0.01; **, P,0.001).
doi:10.1371/journal.pone.0034406.g005
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[70] were used to determine the contents of polysaccharide and
protein, respectively. The composition of the monosaccharide in
PP was measured by gas chromatography by procedures described
previously [71]. The content of polysaccharide and protein in PP
was found to be 85.0762.20 and 11.8560.35% of dry matter
(n=3) with a monosaccharide profile containing mannose, glucose
and galactose with a ratio of 10:5:2. Meanwhile, the polysaccha-
ride-protein complex from another Pleurotus mushroom, Pleurotus
tuber-regium, was also isolated by using the same protocol, coded as
PTR.
Cell culture and chemotherapeutic drugs
Human liver cancer cell lines (Huh7, Hep3B, SMMC-7721 and
HepG2) were maintained in DMEM (Sigma) supplemented with
10% fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA) and 1%
(w/v) penicillin-streptomycin (Invitrogen), and human breast
cancer (T47D), lung adenocarcinoma (A549), human stomach
adenocarcinoma (AGS), prostate cancer (DU145) cell lines and
normal liver cell line (WRL-68) were cultured in RPMI-1640
(Sigma). All cancer cell lines were obtained from ATCC. The
chemotherapeutic drug Cisplatin (DDP) was purchased from
Calbiochem (Darmstadt, Germany). Recombinant human VEGF
(rhVEGF) was purchased from Peprotech (Rocky Hill, NJ).
Plasmid transfection
The plasmid expressing constitutively activated, myristylated
form of AKT (Myr-AKT), was kindly provided by Dr L Larue
(Developmental Genetics of Melanocytes, CNRS-Institut Curie).
The plasmid or vector control was transiently transfected into
Huh7 cells using Lipofectamine 2000 transfection reagent
(Invitrogen) according to the manufacture’s instruction. In brief,
Lipofectamine 2000 reagent and the plasmids were diluted in
Opti-MEM medium (Invitrogen) and then mixed together
followed by 20 min of incubation at room temperature. Next,
the mixtures were added into the cell culture flask and the culture
medium was replaced 24 hr after transfection. The transfected
cells were harvested at indicated time point for analysis.
3-(4, 5-Dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT) assay
Cell viability was measured using MTT proliferation assay.
Briefly, about 1000 cells were seeded in a 96-well plate for 24 hr
before PP was added. Cell viability was determined at 0 hr, 24 hr,
48 hr, 72 hr and 96 hr after treatment of PP. Twenty microliters
of MTT reagent (5 mg/ml in PBS; Sigma) was added at indicated
time point and the cells were incubated for 4 hr at 37uC. Then,
the formazan crystals were dissolved by adding 200 ml DMSO and
taken for optical density (O.D.) measurement at a wavelength of
570 nm. Each data point represented the average of three
independent experiments.
Colony-formation assay
About 1000 cells were seeded in a 6-well plate for 24 hr before
addition of PP or cisplatin. After about 2 weeks, the cells were
fixed in 75% ethanol and stained with 0.1% (v/v) crystal violet.
The experiments were repeated three times.
In vitro cell invasion assay
BioCoat matrigel invasion chambers (BD Biosciences, Bedford,
MA) were used to investigate the cell invasive potential. Briefly, the
chambers were incubated with serum-free DMEM medium for
2h ra t3 7 uC for rehydration prior to use. About 5610
4 cells in
0.5 ml serum-free DMEM medium were delivered into the upper
compartment while the lower compartment was filled with
complete DMEM medium containing 10% FBS as a chemoat-
tractant. After incubation for 24 hr at 37uC and removal of the
cells remaining on the upper surface of the chamber with cotton
swabs, the invaded cells adhering to the bottom surface of the
chamber membrane were fixed in methanol and stained with
0.1% (v/v) crystal violet for 10 min. Images of three different fields
were captured from each membrane. The quantification of the
invaded cells was made by submerging the chambers in 1% SDS
and measuring the absorbance of the solution at 570 nm. The
mean of triplicate assays for each experimental condition was
calculated and values normalized to the untreated cells.
Cell cycle analysis
Cells (1610
6) were seeded in a 6-well culture plate for 24 hr and
treated with of PP. After 48 hr, cell pellets were collected by
trypsinization, fixed in 75% ethanol and kept at 4uC overnight.
The cell pellets were resuspended with suitable propidium iodide
(50 mg/ml) and RNase (1 mg/ml) solution, then incubated for
30 min at 37uC in a water bath. The cell cycle distribution was
determined by the flow cytometry analysis system (Beckman
Coulter, XL-MCL, Miami, FL) and analyzed by using Multicycle
Analysis AV software (Pheoenix Flow Systems, SanDiego, CA).
Western blot analysis
The control and treated cells were harvested at indicated time
points and applied for gel electrophoresis. Briefly, the cell pellets
were treated with lysis buffer (Cell Signaling Technology, Beverly,
MA) with 1% phenylmethanesulfonyl fluoride (PMSF), and kept
on ice for 30 min followed by centrifuge at 10000 g for 30 min at
4uC. The protein concentration in the supernatant collected was
determined by BCA protein assay kit (Thermo, Rockford, IL). An
appropriate amount of protein was mixed with protein loading
buffer [16% (w/v) SDS, 48% (v/v) glycerol, 2.4% (w/v) Tris base,
8% (v/v) b-mercaptoethanol and 0.1% (w/v) bromophenol blue]
and boiled for 10 min at 95uC, then loaded into SDS-
polyacrylamide gel (4% stacking gel and 12% separating gel) for
electrophoresis. The gel was transferred to PVDF membrane and
the membrane was blocked with 5% fat-free dry milk in Tris-
Buffered Saline Tween-20 (TBST) for 1 hr at room temperature
before being washed with TBST and probed with primary
antibodies. The following primary antibodies were used: Bcl-xL,
Bax, caspase-3, cleaved caspase-3, p-AKT, AKT, p-GSK3b,
GSK3b, Vimentin, PTEN, Survivin and poly(ADP-ribose) poly-
merase (PARP) (Cell Signaling Technology); N-cadherin, actin
and VEGF (Santa Cruz Biotechnology, Santa Cruz, CA); and p-
Figure 6. PP suppressed tumor xenograft growth of Huh7 cells in nude mice model. A. Growth curves and representative photographs of
nude mice treated with i.p (left panel) or oral administration (right panel) of PP with the vehicle control (water). Point represents the mean tumor size
with the equation V=(length6width
2)/2. B. The tumors harvested from water-treated or PP-treated mice were fixed, embedded, sectioned, and
applied to Ki-67 immunohistochemical staining and quantification. The number of positively stained nuclei in a minimum of six randomly selected
fields from representative tumor sections divided by the total number of cells is presented in the right panel. C. The tumor tissues were harvested for
western blot. Data are expressed as mean 6 SD. Significant differences between the PP-treated and untreated cells were statistically analyzed by
ANOVA (Tukey’s multiple comparison test; *, P,0.01; **, P,0.001).
doi:10.1371/journal.pone.0034406.g006
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incubated with respective horseradish peroxidase (HRP) conju-
gated secondary antibodies. The signals of immune blot were
developed by ECL Plus Western blotting detection system
(Amersham, Piscataway, NJ) and visualized by exposing a medical
X-ray film (Fuji, Japan) onto the membrane.
VEGF ELISA Kit
Human VEGF Enzyme-Linked Immunosorbent Assay kit
(Pierce Biotechnology, Rockford, IL) was used to determine the
human VEGF concentration in the cell-free culture medium.
According to the manufacture’s instruction, briefly, the condi-
tioned medium treated by PP or control was collected at indicated
time point and added into a microplate coated with anti-human
VEGF165 antibody. After the unbound proteins were removed, a
Figure 7. No obvious adverse effects find in PP-treated mice. A. Hematoxylin and eosin (H&E) staining of lung, liver, kidney from the four
indicated groups of mice. B. Body weight (gram) of the mice treated with PP and control.
doi:10.1371/journal.pone.0034406.g007
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Excess detecting antibody was removed and streptavidin-horse-
radish peroxidase was added to react with TMB Substrate
Solution. The color intensity of the sample was measured at
450 nm and level of VEGF was determined by the ratio of the
absorbance between the treated and untreated cells.
Tumor xenograft nude mouse model
All animal care and experimental procedures were approved by
the Department of Health of the Hong Kong Special Adminis-
trative Region in China under the Animals (Control of
Experiments) Ordinance Chapter 340 (Permit number DH/
HA&P/8/2/1 Pt. 5). Twenty-four 6–8 weeks old male nude
BALB/c mice were supplied by Animal House of The Chinese
University of Hong Kong and randomized into 4 groups (n=6 per
group) and 5610
6 Huh7 cells in PBS mixed with equal volume of
Matrigel (BD Biosciences) were subcutaneously injected into the
flank of nude mice. Five days after the cancer cell inoculation, the
mice were force-fed daily with an aqueous solution of PP (200 mg/
kg) (group 1) and water as control (group 2). PP with a dose of
50 mg/kg was also intraperitoneally (i.p) injected into the tumor-
bearing mice (group 3) thrice a week, whereas the control (group
4) received the vehicle only. The tumor volumes and body weight
were measured every three days and tumor volumes were
calculated with the equation V=(length6width
2)/2. The exper-
iments were carried out for four weeks but if the tumor size
reached 1500 mm
3 during this period of time, the experiment was
terminated. All surgery was performed under sodium pentobar-
bital anesthesia, and all efforts were made to minimize suffering.
At the end of the experiment, the tumors were harvested for
western blot and immunohistochemical analysis. The vital organs
(liver, lung, and kidney) were fixed in 4% paraformaldehyde,
paraffin-embedded and stained by haematoxylin and eosin (H&E).
Immunohistochemistry
Immunohistochemistry was performed as described previously
[72]. In brief, the paraffin-embedded sections from tumor
xenograft were deparaffinized followed by rehydration and
incubation with 0.3% hydrogen peroxide for 30 min. Next,
antigen retrieval was performed in a microwave oven. The slides
were blocked with normal serum, followed by incubation with
primary antibody against Ki-67 (Dako Mississauga, ON) at 4uC
overnight. After the application of the biotinylated secondary
antibodies, including peroxidase-conjugated avidin-biotin complex
and 3, 39-diaminobenzidine (Dako) as chromogen, counterstaining
with the H&E was performed. To determine the ki-67 prolifer-
ation index, the number of positively stained nuclei in a minimum
of six randomly selected fields from representative tumor sections
by the total number of cells was counted.
Statistical Analyses
The experiments were repeated at least three times. The data
from each experiment were presented as the mean 6 standard
derivation (SD). The means among different groups were
evaluated using ANOVA followed by Tukey’s multiple compar-
ison tests for significant differences with P values,0.05.
Supporting Information
Figure S1 No obvious inhibitory effect in liver cancer
cell proliferation upon treatment with extract of another
Pleurotus mushroom, Pleurotus tuber-regium. MTT
assay was applied with polysaccharide and protein complex from
another mushroom Pleurotus tuber-regium (PTR) as control.
(PDF)
Figure S2 Potential cytotoxic activity of PP in normal
cells. A. MTT assay was applied to determine the potential
cytotoxic effect of PP against normal liver cell line WRL-68. B.
Colony-formation assay demonstrated that WRL-68 cells are more
resistant to PP than liver cancer cells.
(PDF)
Figure S3 Effects of PP on the proliferation of other
cancer cell lines. A. Colony-formation assay was used to test the
anti-proliferative effect of PP in other cancer types, including lung
cancer cells (A549), stomach cancer cells (AGS), prostate cancer
cells (DU145) and breast cancer cells (T47D).
(PDF)
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